Subscribe

Bonesupport Holding AB (publ) (BONEX.ST)

SEK219.40 -12.00 (-5.19%)
SE STO Healthcare Medical - Devices
Address Scheelevägen 19 223 70
Lund, SE
CEO Torbjorn Skold
Website bonesupport.com
IPO 2017-06-21
ISIN SE0009858152

Explore sections of this company profile

Also trades on Frankfurt Stock Exchange · 2B4.F (EUR) London Stock Exchange · 0RQO.L (SEK) Other OTC · BOEUF (USD) Stockholm Stock Exchange · BONEX.ST (SEK)
Description

Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SEK219.40 -12.00 (-5.19%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
263.3K
Beta
0.49
Float Shares
52.86M
Free Float %
80.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.78% -11.62% +4.17% +13.54% +13.88% +29.10% -9.60% +99.31% +223.21% +618.13% +618.13%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
219.40
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 5 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
52.29
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Devices: +11.2%
    +30.7% ★ Q1'26: +14.3% (vs Q1'25)
  • ✓
    EPS growth Medical - Devices: +28.5%
    +6.0% Q1'26: +400.0% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Devices: +30.9%
    +10.1% ★ Q1'26: +22.9% (vs Q1'25)
  • ✓
    EBIT margin Medical - Devices: +6.2%
    +23.6% ★ Q1'26: +22.3% (vs Q1'25)
  • ✓
    ROIC Medical - Devices: +3.3%
    +39.4% ★ Q1'26: +45.5% (vs Q1'25)
  • ✗
    Share dilution Medical - Devices: 0.0%
    +0.3% Q1'26: -0.1% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    0.04× ★ Q1'26: 0.05× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.48) × ERP
WACC = 100% × Ke + 0% × Kd (275.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 219.40
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
6 Rev. Ana.
5 EPS Ana. 		Dec 2027
6 Rev. Ana.
5 EPS Ana. 		Dec 2028
6 Rev. Ana.
5 EPS Ana. 		Dec 2029
5 Rev. Ana.
1 EPS Ana. 		Dec 2030
3 Rev. Ana.
1 EPS Ana.
Revenue
129.30M
est: 141.00M (-8.3%)
96.62M
est: 101.18M (-4.5%)
155.46M
est: 157.66M (-1.4%)
180.86M
est: 177.41M (+1.9%)
212.89M
est: 212.10M (+0.4%)
328.82M
est: 322.00M (+2.1%)
591.08M
est: 735.16M (-19.6%)
898.73M
est: 906.18M (-0.8%)
1.17B
est: 1.17B (0.0%)
1.53B
1.50B – 1.56B
+30.1% YoY
1.97B
1.84B – 2.12B
+29.2% YoY
2.54B
2.53B – 2.55B
+28.6% YoY
3.20B
3.05B – 3.36B
+26.2% YoY
4.38B
4.17B – 4.60B
+36.7% YoY
EBITDA
-101.55M
est: -21.22M (-378.6%)
-172.97M
est: -15.23M (-1,036.1%)
-150.87M
est: -23.72M (-536.0%)
-90.91M
est: -26.69M (-240.6%)
-72.39M
est: -31.91M (-126.8%)
-54.34M
est: -48.45M (-12.2%)
28.94M
est: -2.08M (+1,491.0%)
185.75M
est: -2.56M (+7,343.6%)
276.67M
est: -3.32M (+8,420.9%)
-4.32M
-4.42M – -4.23M
-30.1% YoY
-5.59M
-5.99M – -5.20M
-29.2% YoY
-7.18M
-7.22M – -7.15M
-28.6% YoY
-9.07M
-9.52M – -8.62M
-26.2% YoY
-12.39M
-13.01M – -11.79M
-36.7% YoY
EBIT
-110.87M
est: -25.13M (-341.2%)
-173.80M
est: -18.03M (-863.8%)
-158.00M
est: -28.10M (-462.3%)
-98.56M
est: -31.62M (-211.7%)
-80.67M
est: -37.80M (-113.4%)
-63.72M
est: -57.39M (-11.0%)
18.87M
est: -16.27M (+216.0%)
174.92M
est: -20.05M (+972.2%)
276.67M
est: -26.00M (+1,164.0%)
-33.82M
-34.55M – -33.11M
-30.1% YoY
-43.69M
-46.82M – -40.65M
-29.2% YoY
-56.19M
-56.50M – -55.88M
-28.6% YoY
-70.91M
-74.47M – -67.45M
-26.2% YoY
-96.91M
-101.78M – -92.19M
-36.7% YoY
Net Income
-128.87M
est: -142.54M (+9.6%)
-176.41M
est: -220.64M (+20.0%)
-161.06M
est: -187.56M (+14.1%)
-101.41M
est: -105.24M (+3.6%)
-85.53M
est: -77.35M (-10.6%)
-68.17M
est: -57.50M (-18.5%)
245.02M
est: 288.78M (-15.2%)
133.75M
est: 130.34M (+2.6%)
142.15M
est: 162.92M (-12.7%)
307.35M
295.74M – 352.50M
+88.6% YoY
508.43M
461.82M – 565.55M
+65.4% YoY
726.58M
630.03M – 851.74M
+42.9% YoY
834.53M
781.66M – 889.02M
+14.9% YoY
—
— – —
-100.0% YoY
SGA
150.34M
est: 128.61M (+16.9%)
191.66M
est: 92.29M (+107.7%)
225.60M
est: 143.80M (+56.9%)
200.91M
est: 161.82M (+24.2%)
221.97M
est: 193.46M (+14.7%)
311.75M
est: 293.70M (+6.1%)
461.62M
est: 597.25M (-22.7%)
609.34M
est: 736.19M (-17.2%)
719.26M
est: 954.57M (-24.7%)
1.24B
1.22B – 1.27B
+30.1% YoY
1.60B
1.49B – 1.72B
+29.2% YoY
2.06B
2.05B – 2.07B
+28.6% YoY
2.60B
2.48B – 2.73B
+26.2% YoY
3.56B
3.38B – 3.74B
+36.7% YoY
EPS
-3.24
est: -2.14 (-51.4%)
-3.46
est: -3.31 (-4.5%)
-3.10
est: -2.82 (-10.1%)
-1.72
est: -1.58 (-8.9%)
-1.34
est: -1.16 (-15.4%)
-1.06
est: -0.86 (-22.8%)
3.77
est: 4.43 (-14.8%)
2.04
est: 1.95 (+4.6%)
2.16
est: 2.44 (-11.4%)
4.94
4.43 – 5.28
+102.5% YoY
7.56
6.92 – 8.47
+53.0% YoY
10.66
9.43 – 12.76
+41.1% YoY
12.50
11.71 – 13.31
+17.2% YoY
—
— – —
-100.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-28 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-27 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-26 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-25 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-22 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-21 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-20 B 3/5 1/5 5/5 5/5 4/5 1/5 1/5
2026-05-19 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-18 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-15 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-13 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-12 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-11 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-08 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-07 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-06 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-05 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-05-04 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-04-30 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-04-29 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-04-28 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-04-27 B 3/5 1/5 5/5 5/5 3/5 1/5 1/5
2026-04-24 B- 3/5 1/5 5/5 5/5 2/5 1/5 1/5
2026-04-23 B- 3/5 1/5 5/5 5/5 2/5 1/5 1/5
2026-04-22 B- 2/5 1/5 4/5 5/5 2/5 1/5 1/5
2026-04-21 B- 2/5 1/5 4/5 5/5 2/5 1/5 1/5
2026-04-20 B- 2/5 1/5 4/5 5/5 2/5 1/5 1/5
2026-04-17 B- 2/5 1/5 4/5 5/5 2/5 1/5 1/5
2026-04-16 B- 2/5 1/5 4/5 5/5 2/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
254.79M
OE per share TTM
3.82
Owner's Yield
1.68%
Maintenance CapEx ratio
1.91%
Maint CapEx / Avg PPE
4.1%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 77 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares OMX Stockholm Capped UCITS ETF OM3X.DE 0.18% 381.5K 0.10%
2 iShares Ageing Population UCITS ETF AGED.L 0.13% 1.15M 0.40%
3 State Street SPDR S&P International Small Cap ETF GWX 0.09% 755.4K 0.40%
4 iShares MSCI Europe Small-Cap ETF IEUS 0.08% 147.4K 0.41%
5 Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L 0.08% 2.57M 0.30%
6 Avantis International Small Cap Equity ETF AVDS 0.07% 207.1K 0.30%
7 iShares International Small-Cap Equity Factor ETF ISCF 0.06% 410.3K 0.24%
8 Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE 0.06% 196.1K 0.23%
9 Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA 0.06% 196.1K 0.23%
10 Schwab International Small-Cap Equity ETF SCHC 0.05% 2.94M 0.06%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
1.98M
Shares Outstanding
65.86M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Torbjorn Skold Chief Executive Officer 4M male
Håkan Johansson Chief Financial Officer 3M male
Fergus MacLeod GM & Executive Vice President of Commercial Operations of EUROW — male
Helena L. Brandt Executive Vice President of Human Resources — female
Anna Stegmark Executive Vice President of Quality Management & Regulatory Affairs — female
Michael Diefenbeck Executive Vice President of Medical & Clinical Affairs and Chief Medical Officer — —
Michael Roth GM & Executive VP of Commercial Operations of US — male
Michael Wrang Mortensen Executive Vice President of Global R&D and Operations — male
Annelie Aava Vikner Executive Vice President of Global Marketing — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices